tirzepatide ban update 🚨 Important on Compounded 🚨, As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable COMPOUNDED TIRZEPATIDE ENDS TOMORROW! What

On the other hand, the proportion of muscle mass an individual retains is associated with longevity outcomes.(5) To help counteract muscle and bone loss, health professionals can recommend strategies to help maintain bone and muscle mass, such as following a strength training regimen and consuming adequate protein

Summary: In Phase 2 clinical trials, retatrutide was typically initiated at 2 mg once weekly via subcutaneous injection, with gradual dose escalation over several months under close medical supervision

Frequently Asked Questions Does GLP-1 for weight loss really work

Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity

Oct 6: People with a range of rheumatic diseases have a new treatment delivery option after the FDA approved an intravenous formulation of Novartis IL-17A antagonist Cosentyx (secukinumab)

doi: 10.1016/j.eprac.2023.02.001 62